Literature DB >> 20619080

Incidence of surgical-site infections in orthopaedic surgery: a northern Italian experience.

A Castella1, P A Argentero, E C Farina, L Charrier, E M Brach Del Prever, C M Zotti.   

Abstract

SUMMARYA prospective cohort study with a 1-year telephone follow-up was performed to estimate the incidence of surgical-site infections (SSIs) in hip and knee prostheses. Twenty-five public hospitals equipped with orthopaedic units in two Italian regions were involved. An 8-month surveillance period was set to obtain significant data at a regional level and data were collected by the infection control nurses of each centre. One-year follow-up was completed in 75% of cases. SSIs were recorded in 45 cases (incidence rate 1·9/100 person-years, 95% CI 1·4-2·5). Thirty-six percent of SSIs were diagnosed during hospitalization and 95·3% within 90 days post-operation. This incidence is similar to that reported by European and USA surveillance systems. The proposed investigative method proved to be reliable and feasible. A prolonged surveillance for at least 3 months post-operation yields a good estimate of SSI in joint replacements.

Entities:  

Mesh:

Year:  2010        PMID: 20619080     DOI: 10.1017/S0950268810001627

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

1.  Prevention of surgical site infections in bone and joint procedures.

Authors:  Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

2.  Appropriate use of antimicrobial prophylaxis: an observational study in 21 surgical wards.

Authors:  Marco Testa; Michela Stillo; Sebastian Giacomelli; Silvia Scoffone; Pier Angelo Argentero; Enzo Carlo Farina; Carla Maria Zotti
Journal:  BMC Surg       Date:  2015-05-14       Impact factor: 2.102

3.  Surveillance of healthcare-associated infections in Piemonte, Italy: results from a second regional prevalence study.

Authors:  Lorena Charrier; Pier Angelo Argentero; Enzo C Farina; Roberto Serra; Francesco Mana; Carla M Zotti
Journal:  BMC Public Health       Date:  2014-06-05       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.